Jagsonpal PharmaceuticalsJAGSNPHARM 
$5.134.24%24h
4.24%24h
Global rank19531
Market cap$134.49M
Change 7d4.09%
YTD Performance10.25%
SP500 benchmarkUnderperform
P/E0.50
P/S4.77
Revenue$28.19M
Earnings$3.18M
Dividend yield-
Main Sector
Healthcare
Category
Jagsonpal Pharmaceuticals (JAGSNPHARM) Net Assets
JAGSNPHARM Net Assets in 2023: $1.59B
As of 11 Sept 2024, Jagsonpal Pharmaceuticals net assets is $1.59B, an increase of 19.68% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Jagsonpal Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Jagsonpal Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
JAGSNPHARM Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $1.59B | 19.68% |
| 2022 | $1.33B | 6.31% |
| 2021 | $1.25B | 12.46% |
| 2020 | $1.11B | 104.74% |
| 2019 | $542.32M | - |
View the Top Net Assets Companies
